3B Future Health Fund
Investor profile
Venture capital
Deals
6
distinct rounds
Companies
6
backed
Active span
2022–2024
3 yrs
Total round €
€205M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Claris Ventures3
- Schroders Capital3
- 2Invest2
- CDP Venture Capital2
- VI Partners2
- ACE & Company1
- adMare BioInnovations1
- Alef 61
- Astellas Venture Management1
- British Patient Capital1
- Caribou Property Limited1
- Club degli Investitori1
- CRT Pioneer Fund1
- CTI Life Sciences1
- EIC Fund1
- Ersel1
- Evolution Ventures1
- Indaco Venture Partners1
- INKEF Capital1
- Italian Angels for Growth1
- M Ventures1
- Novartis Venture Fund1
- Omnes Capital1
- Panacea Venture1
- Seroba Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| iOnctura | Switzerland | 1 | €80M |
| Domain Therapeutics | France | 1 | €40M |
| Epsilogen | UK | 1 | €37M |
| Sibylla Biotech | Italy | 1 | €23M |
| Kither Biotech | Italy | 1 | €19M |
| NeoPhore | UK | 1 | €6.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| iOnctura | Series B | €80M | 2024-06 |
| Domain Therapeutics | Series A | €40M | 2022-05 |
| Epsilogen | Series B | €37M | 2022-03 |
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Kither Biotech | Series B | €19M | 2022-03 |
| NeoPhore | Series B | €6.9M | 2023-01 |